热门资讯> 正文

DBV Technologies GAAP每股收益为-1.05美元

2026-03-27 17:16

DBV Technologies press release (DBVT): FY GAAP EPS of -$1.05.
On December 31, 2025, DBV held $194.2 million in cash and cash equivalents compared to $32.5 million of cash and cash equivalents on December 31, 2024.
Net cash used for operating activities was $121.2 million and $104.5 million for the years ended December 31, 2025, and 2024, respectively.

More on DBV Technologies

DBV Technologies S.A. (DBVT) Presents at American Academy of Allergy, Asthma & Immunology (AAAAI) 2026 Annual Meeting - Slideshow
Seeking Alpha’s Quant Rating on DBV Technologies
Historical earnings data for DBV Technologies
Financial information for DBV Technologies

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。